Cite
HARVARD Citation
Wu, Q. et al. (2022). Efficacy and safety of empagliflozin at different doses in patients with type 2 diabetes mellitus: A network meta‐analysis based on randomized controlled trials. Journal of clinical pharmacy and therapeutics. pp. 270-286. [Online].